Gastric and colorectal cancers are the leading causes of cancer deaths worldwide, and surgery is the only curative treatment in patients with localized cancer. Over the past two decades, the surgical management of gastric and colorectal cancers has evolved substantially. Through the improved understanding of the function and anatomy of the stomach and intestine, combined with the progress made regarding surgical techniques, accumulation of surgical experience, and multimodal treatments, both short- and long-term outcomes following surgical resection for primary and metastatic gastric and colorectal cancers have been improved dramatically. In the era of new diagnostic and therapeutic interventions, practice is now moving towards personalized surgical management.
The goal of our Research Topic is to shed light on the progress made in the past years in the field of surgical management of primary and metastatic gastric and colorectal cancers, and on the future challenges to provide a thorough overview of the field as it presently stands. We aim to 1) disseminate high-quality clinical and translational surgical oncology research on gastric and colorectal cancers; 2) inspire, inform, and provide both direction and guidance to surgeons and researchers in the field. Submissions that will contribute to the advancement of surgical oncology are welcome. These may include but are not limited to the followings:
• Surgical treatments or techniques in primary/metastatic gastric and colorectal cancers
• Supplemental, adjuvant, or neoadjuvant therapies in pre/post-surgical patients
• Prognostic impact of gastric and colorectal surgeries
• Methods of investigation and patient evaluation/outcomes
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Gastric and colorectal cancers are the leading causes of cancer deaths worldwide, and surgery is the only curative treatment in patients with localized cancer. Over the past two decades, the surgical management of gastric and colorectal cancers has evolved substantially. Through the improved understanding of the function and anatomy of the stomach and intestine, combined with the progress made regarding surgical techniques, accumulation of surgical experience, and multimodal treatments, both short- and long-term outcomes following surgical resection for primary and metastatic gastric and colorectal cancers have been improved dramatically. In the era of new diagnostic and therapeutic interventions, practice is now moving towards personalized surgical management.
The goal of our Research Topic is to shed light on the progress made in the past years in the field of surgical management of primary and metastatic gastric and colorectal cancers, and on the future challenges to provide a thorough overview of the field as it presently stands. We aim to 1) disseminate high-quality clinical and translational surgical oncology research on gastric and colorectal cancers; 2) inspire, inform, and provide both direction and guidance to surgeons and researchers in the field. Submissions that will contribute to the advancement of surgical oncology are welcome. These may include but are not limited to the followings:
• Surgical treatments or techniques in primary/metastatic gastric and colorectal cancers
• Supplemental, adjuvant, or neoadjuvant therapies in pre/post-surgical patients
• Prognostic impact of gastric and colorectal surgeries
• Methods of investigation and patient evaluation/outcomes
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.